2021

1. Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses

   Emerging Microbes and Infections, Vol. 10, Núm. 1, pp. 1931-1946